Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Loading articles...

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.

Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Tag

#ARS Pharmaceuticals (SPRY)

1 article found with this tag

Showing 1 to 1 of 1 articles

News & Comments

ARS Pharmaceuticals Announces FDA Approval of neffy® for Type I Allergic Reactions, Including Anaphylaxi in Pediatric Patients

ARS Pharmaceuticals SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE), ARS Pharmaceuticals (SPRY) announced that the U.S. FDA has approved neffy® 1 mg (epinephrine nasal spray) for the treatment of Type I...

Prohost Biotech

Mar 6, 2025

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.